Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
39.76%
Threshold
Crossed downwards
Timeline
Published
03.08.2023
Transaction
25.07.2023
Voting rights breakdown
Voting rights acquired15.94%
Voting rights sold39.76%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAN7S00038
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
Regarding certain sale positions
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open